The bone marrow (BM) microenvironment in hematological malignancies (HMs) comprises
heterogeneous populations of neoplastic and nonneoplastic cells. Cancer stem cells …

Peripheral demyelinating diseases entail damage to axons and Schwann cells in the
peripheral nervous system. Because of poor prognosis and lack of a cure, this group of …

The adult bone marrow (BM) niche is a complex entity where a homeostatic hematopoietic
system is maintained through a dynamic crosstalk between different cellular and non …

One of the most crucial components of regenerative medicine is the controlled differentiation
of embryonic or adult stem cells into the desired cell lineage. Although most of the reported …

Trending three-dimensional tissue engineering platforms developed via biofabrication and
bioprinting of exocrine glands are on the rise due to a commitment to organogenesis …

As caretakers of the hematopoietic system, hematopoietic stem cells assure a lifelong supply
of differentiated populations that are responsible for critical bodily functions, including …

Transplantation of hematopoietic stem cells (HSCs) derived from umbilical cord blood (UCB)
has been taken into account as a therapeutic approach in patients with hematologic …

Ex vivo expansion of hematopoietic progenitors is considered as an attractive tool to
increase the number of stem and progenitor cells (HSPCs) for cell therapy. The efficacy of ex …

Hematopoietic stem cell (HSC) transplantation to treat haematological disorders is greatly
restricted by poor cell availability. Ex vivo expansion of HSCs as a strategy to overcome this …

Hematopoietic stem cell (HSC) transplantation to treat haematological disorders is greatly
restricted by poor cell availability. Ex vivo expansion of HSCs as a strategy to overcome this …